Umbilical Cord Ulceration after Prenatal Diagnosis of Duodenal Atresia with Interstitial Deletion of Chromosome 13q: A Case ReportMiyake H.a · Yamamoto A.b · Yamada T.b · Okazaki K.c · Morita K.c · Kondo M.c · Ishida T.d · Nishina T.d · Yokota A.b · Nakai A.b · Takeshita T.b
Departments of Obstetrics and Gynecology,aJapanese Red Cross Katsushika Maternity Hospital and bNippon Medical School, and cNeonatal Unit and dDivision of Pediatric Surgery, Tokyo Metropolitan Hachioji Children’s Hospital, Tokyo, Japan
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
Article / Publication Details
Umbilical cord ulceration complicated by massive local hemorrhage may be a lethal event in the fetus, and this ulceration has been reported to be associated with upper intestinal atresia. The diagnosis of umbilical cord bleeding is difficult. We present a case of umbilical cord ulceration, hemorrhage, and duodenal atresia which had, in addition, an interstitial deletion of chromosome 13q. A female infant weighing 1,691 g was delivered by cesarean section at 34 weeks of gestation and had resuscitation and laparotomy. Just before the cesarean section, ultrasonography showed a ‘double bubble’ sign and a linear shadow, suggesting fibrin in the amniotic cavity. This finding may help in the diagnosis of bleeding from the cord.
© 2008 S. Karger AG, Basel
- Lawrence MJ, Ford WD, Furness ME, Hayward T, Wilson T: Congenital duodenal obstruction: early antenatal ultrasound diagnosis. Pediatr Surg Int 2000;16:342–345.
- Brantberg A, Blaas HG, Salvesen KA, Haugen SE, Mollerlokken G, Eik-Nes SH: Fetal duodenal obstructions: increased risk of prenatal sudden death. Ultrasound Obstet Gynecol 2002;20:439–446.
- Bendon RW, Tyson RW, Baldwin VJ, Cashner KA, Mimouni F, Miodovnik M: Umbilical cord ulceration and intestinal atresia: a new association? Am J Obstet Gynecol 1991;164:582–586.
- Ohyama M, Itani Y, Yamanaka M, Imaizumi K, Nishi T, Ijiri R, Tanaka Y: Umbilical cord ulcer: a serious in utero complication of intestinal atresia. Placenta 2000;21:432–435.
- Anami A, Morokuma S, Tsukimori K, Kondo H, Nozaki M, Sueishi K, Nakano H: Sudden fetal death associated with both duodenal atresia and umbilical cord ulcer: a case report and review. Am J Perinatol 2006;23:183–188.
- Shimizu S, Kawagishi R, Arimoto-Ishida E, Wada K, Shimoya K, Murata Y: Fetal hemorrhage associated with congenital intestinal atresia. J Obstet Gynaecol Res 2003;29:312–316.
- Khong TY, Ford WD, Haan EA: Umbilical cord ulceration in association with intestinal atresia in a child with deletion 13q and Hirschsprung’s disease. Arch Dis Child Fetal Neonatal Ed 1994;71:F212–F213.
- Yamanaka M, Ohyama M, Koresawa M, Kawataki M, Ohsaki I, Tanaka Y: Umbilical cord ulceration and intestinal atresia. Eur J Obstet Gynecol Reprod Biol 1996;70:209–212.
- Hidaka N, Chiba Y: Intrauterine hemorrhage from an umbilical cord ulcer associated with fetal duodenal atresia: a case report. Arch Gynecol Obstet 2007;275:219–222.
Jones KL: Deletion 13q syndrome; in Jones KL (ed): Smith’s Recognizable Patterns of Human Malformations, ed 6. Philadelphia, Saunders, 2006.
- Brown S, Russo J, Chitayat D, Warburton D: The 13q– syndrome: the molecular definition of a critical deletion region in band 13q32. Am J Hum Genet 1995;57:859–866.
Schinzel A: Chromosome 13q; in Schinzel A (ed): Catalogue of Unbalanced Chromosome Aberrations in Man, ed 2. Berlin, de Gruyter, 2001.
- Kimura T, Usui N, Kamata S, Kawahara H, Sawai T, Hirano S, Wada K, Tomimatsu T, Fukuda H, Okada A: Umbilical cord ulcer associated with fetal jejunal atresia: report of 2 cases. Fetal Diagn Ther 2003;18:144–147.
- Khurana A, Huettner PC, Cole FS: Umbilical cord ulceration as a cause of hypoxic-ischemic encephalopathy: report of a case and review of the literature. J Perinatol 1995;15:423–425.
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.